Evaluation of an Experimental Homogeneous Enzyme Immuno-Assay for the Quantitation of Phenytoin and Phenobarbitone in Serum or Plasma
Since the first reports on the relationship of serum anti-epileptic drug concentrations to seizure control, the goal of the pharmacologist and clinical chemist has been to provide rapid and accurate drug level determinations to the clinician. The application of gas liquid chromatography (GLC) to the detection of several anti-epileptic drugs in the same serum sample in 1969 and the marked increase in the number of GLC methods available has greatly enhanced our ability to achieve adequate seizure control (in epileptic patients). Extensive reviews of anti-epileptic drug methodology (Rose et al., 1971; Meijer et al., 1973), and of the application of blood levels to seizure control (Woodbury et al., 1972; Kutt and Louis, 1972) have been published.
KeywordsBarbituric Acid Immunoassay System Emit System Tris Hydrochloride Enzyme Immunoassay System
Unable to display preview. Download preview PDF.
- Cook, C. E., Kepler, J. A., Christensen, H. D.: Antiserum to diphenylhydantoin preparation and characterization. Res. Comm. Chem. Path. Pharmacol. 5, 767 (1973).Google Scholar
- Meijer, J. W. A., Meinardi, H., Gardner-Thorpe, C., van der Kleijn, E. (Editors): Methods of analysis of anti-epileptic drugs. Excerpta Med. (Amst.) 1973.Google Scholar
- Rose, S. W., Smith, L. D., Penry, J. K.: Clinical value and methods of blood level determinations of anti-epileptic drugs. US Department of Health Education and Welfare. Washington, DC: Public Health Service, 1971.Google Scholar
- Woodbury, D. M., Penry, J. K., Schmidt, R. P. (Editors): Antiepileptic Drugs. New York: Raven Press 1972.Google Scholar